Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection

Transplant International

Volumn 20, Issue 5, 2007, Pages 460-466

  Dudler, Jean ^a   Simeoni, Eleonora ^a   Fleury, Sylvain ^a   Li, Jianping ^a,b   Pagnotta, Maria ^a   Pascual, Manuel ^c,d   Von Segesser, Ludwig K ^a,c,d   Vassalli, Giuseppe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Geneva Lausanne Transplantation Network   (Switzerland)

^d Geneva Lausanne Transplantation Network   (Switzerland)

Author keywords

Gene therapy; Heart transplantation; Interleukin 18; Interleukin 18 binding protein

Indexed keywords

ADENOVIRUS VECTOR; CD4 ANTIGEN; CD8ALPHA ANTIGEN; CYTOKINE; HYBRID PROTEIN; INTERLEUKIN 18 BINDING PROTEIN; RANTES; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LEWIS RAT; MACROPHAGE MIGRATION INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOVIRIDAE; ANIMALS; CYTOKINES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; MALE; MYOCARDIUM; RATS; RATS, INBRED F344; RATS, INBRED LEW; TRANSPLANTS; UP-REGULATION;

EID: 34047199500     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00457.x     Document Type: Article

References (33)

1. Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989; 57: 590.
2. Kim Y-M, Im JY, Han SH, et al. IFN-γ up-regulates IL-18 gene expression via IFN consensus sequence-binding protein and activator protein-1 elements in macrophages. J Immunol 2000; 165: 3198.
3. Dinarello CA. Targeting interleukin 18 with interleukin 18 binding protein. Ann Rheum Dis 2000; 59(Suppl. 1): i17.
4. McInnes IB, Gracie JA, Leung BP, et al. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000; 21: 312.
5. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12: 53.
6. Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8: 383.
7. Daemen MA, van't Veer C, Wolfs TG, Buurman WA. Ischemia-reperfusion induced IFN-γ up-regulation: involvement of IL-12 and IL-18. J Immunol 1999; 162: 5506.
8. Yoshida A, Takahashi HK, Nishibori M, et al. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC. Cell Immunol 2001; 210: 106.
9. Baxevanis CN, Gritzapis AD, Papamichail M. In vivo anti-tumor activity of NKT cells activated by the combination of IL-12 and IL-18. J Immunol 2003; 171: 2953.
10. Arnold D, Wasem C, Juillard P, et al. IL-18-independent cytotoxic T lymphocyte activation and IFN-gamma production during experimental acute graft-versus-host disease. Int Immunol 2002; 14: 503.
11. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161: 3400.
12. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 response. Immunity 1999; 10: 127.
13. Kim SH, Eisenstein M, Reznikov L, et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000; 97: 1190.
14. Im SH, Kim SH, Azam T, et al. Rat interleukin-18 binding protein: cloning, expression, and characterization. J Interferon Cytokine Res 2002; 22: 321.
15. Fantuzzi G, Banda NK, Guthridge C, et al. Generation and characterization of mice transgenic for human IL-18-binding protein isoform a. J Leukoc Biol 2003; 74: 889.
16. Wu CJ, Kurbegov D, Lattin B, et al. Cytokine gene expression in human cardiac allograft recipients. Transpl Immunol 1994; 2: 199.
17. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. A sequential study. Transplantation 1994; 57: 1333.
18. Striz I, Krasna E, Honsova E, et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett 2005; 99: 30.
19. Simon T, Opelz G, Wiesel M, Pelzl S, Ott RC, Susal C. Serial peripheral blood interleukin-18 and perforin gene expression measurements for prediction of acute kidney graft rejection. Transplantation 2004; 77: 1589.
20. de Oliveira JG, Xavier PD, Sampaio SM, Tavares IS, Mendes AA. The synthesis by fine-needle aspiration biopsy cultures of IL-7, IL-16 and IL-18 is significantly associated with acute rejection in kidney transplants. Nephron 2002; 92: 622.
21. Yamaguchi Y, Matsumura F, Liang J, et al. Reduced interleukin-12, interleukin-18, and interferon-gamma production with prolonged rat hepatic allograft survival after donor-specific blood transfusion. Dig Dis Sci 2000; 45: 2429.
22. Affleck DG, Bull DA, Albanil A, et al. Interleukin-18 production following murine cardiac transplantation: Correlation with histologic rejection and induction of IFN-gamma. J Interferon Cytokine Res 2001; 21: 1.
23. Dudler J, Salvi R, Driscoll R, So AK. A simple system for rapid generation of recombinant adenoviruses by ligation. Arthritis Res 2002; 4(Suppl. 1): 112 (abstr.) .
24. Fleury S, Driscoll R, Simeoni E, et al. Helper-dependent adenovirus vectors devoid of all viral genes cause less myocardial inflammation compared with first-generation adenovirus vectors. Basic Res Cardiol 2004; 99: 247.
25. Dudler J, Li J, Pagnotta M, Pascual M, von Segesser LK, Vassalli G. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation 2006; 82: 1733.
26. Azzawi M, Hasleton PS, Geraghty PJ, et al. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages. J Heart Lung Transplant 1998; 17: 881.
27. Uguccioni M, Blaser A, Stallmach T, et al. Chemokine expression in heart transplantation. J Am Coll Cardiol 1998: 59A (abstr.).
28. Puren AJ, Fantuzzi G, Gu Y, Su MS-S, Dinarello CA. Interleukin-18 (IFN-γ-inducing factor) induces IL-1 and IL-8 via TNF production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998; 101: 711.
29. Ariel A, Novick D, Rubinstein M, Dinarello CA, Lider O, Hershkoviz R. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components. J Leukoc Biol 2002; 72: 192.
30. Dinarello CA. Novel targets for interleukin 18 binding protein. Ann Rheum Dis 2001; 60(Suppl. 3): iii18.
31. Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferon-γ- inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells. Cell Immunol 1997; 173: 230.
32. Leung BP, Culshaw S, Gracie JA, et al. A role for IL-18 in neutrophil activation. J Immunol 2001; 167: 2879.
33. Shiraishi M, Csete M, Yasunaga C, et al. The inhibitory cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model. J Surg Res 1995; 58: 465.